Open AccessDevelopment of intracardiac thrombus in a young patient with antiphospholipid syndrome while she was on rivaroxaban: Case report and literature review
Author(s) -
Abdelmahmuod Elabbass A.,
Hamad Abdelrahman,
Almaghraby Ahmed,
Mohamed Samah,
Alkuwari Maryam
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4137
Subject(s) - medicine , antiphospholipid syndrome , intracardiac injection , rivaroxaban , thrombus , cardiology , pulmonary embolism , thrombosis , warfarin , intensive care medicine , atrial fibrillation
The probability of right heart thrombus co‐existence should be considered in patients with antiphospholipid syndrome (APS) who have pulmonary and cardiac symptoms. The prevention and management of intracardiac thrombotic events include early use of anticoagulation therapy.